Kbc Group Nv Invitae Corp Transaction History

Kbc Group Nv

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$14.7 - $28.67 $17,640 - $34,404	-1,200 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$28.43 - $44.67 $56,860 - $89,340	-2,000 Reduced 62.5%	1,200 $52,000
Q2 2020 Aug 10, 2020	SELL	$11.71 - $30.29 $82,789 - $214,150	-7,070 Reduced 68.84%	3,200 $97,000
Q4 2019 Feb 11, 2020	BUY	$15.02 - $20.57 $141,638 - $193,975	9,430 Added 1122.62%	10,270 $166,000
Q2 2019 Dec 03, 2019	BUY	$17.37 - $26.27 $14,590 - $22,066	840 New	840 $20,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.